X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9656) 9656
Newsletter (563) 563
Newspaper Article (98) 98
Book Chapter (87) 87
Dissertation (40) 40
Conference Proceeding (19) 19
Publication (13) 13
Magazine Article (12) 12
Streaming Video (3) 3
Transcript (3) 3
Web Resource (2) 2
Book / eBook (1) 1
Book Review (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gemcitabine (9885) 9885
science & technology (6160) 6160
life sciences & biomedicine (5735) 5735
humans (5373) 5373
deoxycytidine - analogs & derivatives (4873) 4873
oncology (4269) 4269
chemotherapy (3381) 3381
female (3357) 3357
pancreatic cancer (3173) 3173
cancer (3157) 3157
male (2835) 2835
middle aged (2763) 2763
deoxycytidine - administration & dosage (2754) 2754
aged (2669) 2669
antineoplastic combined chemotherapy protocols - therapeutic use (2136) 2136
adult (2018) 2018
research (1664) 1664
treatment outcome (1551) 1551
care and treatment (1544) 1544
pancreatic neoplasms - drug therapy (1511) 1511
deoxycytidine - therapeutic use (1451) 1451
cisplatin (1269) 1269
deoxycytidine - adverse effects (1236) 1236
cell line, tumor (1159) 1159
pharmacology & pharmacy (1145) 1145
deoxycytidine - pharmacology (1131) 1131
pancreatic neoplasms - pathology (1063) 1063
metastasis (1056) 1056
antineoplastic combined chemotherapy protocols - adverse effects (1038) 1038
animals (1002) 1002
tumors (930) 930
cancer therapies (915) 915
lung neoplasms - drug therapy (888) 888
drug therapy (882) 882
aged, 80 and over (871) 871
antimetabolites, antineoplastic - therapeutic use (815) 815
medicine & public health (804) 804
analysis (803) 803
paclitaxel (801) 801
apoptosis (787) 787
health aspects (777) 777
clinical trials (774) 774
patients (731) 731
prognosis (731) 731
antineoplastic agents (725) 725
carcinoma, non-small-cell lung - drug therapy (725) 725
oncology, experimental (722) 722
mice (703) 703
cisplatin - administration & dosage (690) 690
antimitotic agents (680) 680
survival analysis (661) 661
disease-free survival (644) 644
survival rate (641) 641
antimetabolites, antineoplastic - administration & dosage (635) 635
neoplasm staging (625) 625
dosage and administration (605) 605
drug administration schedule (604) 604
adenocarcinoma (598) 598
adenocarcinoma - drug therapy (588) 588
toxicity (550) 550
medical prognosis (546) 546
antimetabolites, antineoplastic - pharmacology (544) 544
survival (540) 540
dose-response relationship, drug (532) 532
metastases (530) 530
antineoplastic combined chemotherapy protocols - administration & dosage (509) 509
lung cancer (501) 501
breast cancer (488) 488
antineoplastic agents - therapeutic use (481) 481
carboplatin (481) 481
retrospective studies (470) 470
docetaxel (461) 461
surgery (456) 456
apoptosis - drug effects (439) 439
lung neoplasms - pathology (436) 436
antimetabolites, antineoplastic - adverse effects (435) 435
combined modality therapy (432) 432
cancer research (421) 421
radiotherapy (420) 420
pancreatic neoplasms - metabolism (419) 419
pharmacology/toxicology (404) 404
lung cancer, non-small cell (403) 403
drug resistance, neoplasm (401) 401
gene expression (399) 399
cytotoxicity (391) 391
physical fitness (391) 391
cell proliferation - drug effects (386) 386
neoplasm metastasis (384) 384
patient outcomes (384) 384
hematology, oncology and palliative medicine (383) 383
studies (381) 381
proteins (380) 380
medical research (377) 377
paclitaxel - administration & dosage (375) 375
pancreatic neoplasms - mortality (374) 374
pancreas (372) 372
drug resistance (371) 371
medicine (370) 370
non-small cell lung cancer (370) 370
oxaliplatin (369) 369
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10073) 10073
Japanese (156) 156
French (97) 97
German (77) 77
Chinese (75) 75
Korean (61) 61
Spanish (33) 33
Italian (11) 11
Portuguese (11) 11
Polish (10) 10
Turkish (10) 10
Russian (7) 7
Czech (6) 6
Persian (3) 3
Slovak (3) 3
Catalan (2) 2
Hungarian (2) 2
Romanian (2) 2
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of pharmaceutics, ISSN 0378-5173, 01/2015, Volume 478, Issue 1, p. 308
Display Omitted 
Gemcitabine
Journal Article
Der Onkologe, ISSN 0947-8965, 05/2019, Volume 25, Issue 5, p. 466
Journal Article
Chirurg, ISSN 0009-4722, 10/2016, Volume 87, Issue 10, p. 892
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00104-016-0282-2 
Gemcitabine
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 05/2019, Volume 112, Issue 2, pp. 200 - 210
The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing. The aim of the study was to provide reference survival data for patients with advanced... 
Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 05/2013, Volume 8, Issue 5
Kahramanoğulları, Fantaccini G, Lecca P, Morpurgo D, Priami C (2012) Algorithmic Modeling Quantifies the Complementary Contribution of Metabolic Inhibitions to... 
Gemcitabine | Metabolism | Algorithms
Journal Article
Oncotarget, ISSN 1949-2553, 06/2019, Volume 10, Issue 38, pp. 3579 - 3580
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 21, pp. 15780 - 15791
Chemotherapy with gemcitabine and nab-paclitaxel (gemcitabine/nab-paclitaxel) is recommended for unresectable pancreatic cancer. However, the therapeutic... 
NF-κB | Gemcitabine/nab-paclitaxel | IMiDs | Pancreatic cancer | P53
Journal Article
British journal of cancer, ISSN 1532-1827, 09/2015, Volume 113, Issue 7, pp. 989 - 995
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A2193 - A2193
Angiography was deferred and the patient was started on medical therapy for coronary vasospasm. Conclusion This case highlights a malignant course of... 
Cardiac arrhythmia | Chemotherapy | Medical imaging | Gemcitabine | Vasoconstriction | Angina pectoris | Cisplatin
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 10/2017, Volume 77, Issue 20, pp. 5503 - 5517
Pancreatic adenocarcinoma is moderately responsive to gemcitabine-based chemotherapy, the most widely used single-agent therapy for pancreatic cancer. Although... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Adenocarcinoma - pathology | Pancreatic Neoplasms - metabolism | Humans | Carcinoma, Pancreatic Ductal - metabolism | Deoxycytidine - pharmacology | Drug Resistance, Neoplasm | Lipids - biosynthesis | Pancreatic Neoplasms - drug therapy | Adenocarcinoma - metabolism | Antimetabolites, Antineoplastic - pharmacology | Female | Endoplasmic Reticulum Stress - drug effects | Signal Transduction | Pancreatic Neoplasms - pathology | Random Allocation | Adenocarcinoma - drug therapy | Carcinoma, Pancreatic Ductal - pathology | Xenograft Model Antitumor Assays | Carcinoma, Pancreatic Ductal - drug therapy | Animals | Mice, Nude | Cell Line, Tumor | Mice | Deoxycytidine - analogs & derivatives | Endoplasmic Reticulum Stress - physiology | Adenocarcinoma | Cell culture | Surgical implants | Animal models | Gemcitabine | Lipids | Genomes | Biosynthesis | Tissues | Thapsigargin | Lipid metabolism | Inhibition | Lipogenesis | Stresses | Cell survival | Implantation | Metabolism | Patients | Fatty acids | Fatty-acid synthase | Stress | Chemotherapy | Pancreatic cancer | Medical prognosis | Genetic engineering | In vivo methods and tests | Synergistic effect | Endoplasmic reticulum | Cancer | Apoptosis | Index Medicus | cancer metabolism | pancreatic cancer | cancer stem cells | gemcitabine resistance | FASN
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2018, Volume 379, Issue 25, pp. 2395 - 2406
Journal Article
Cancers, ISSN 2072-6694, 11/2018, Volume 10, Issue 11, pp. 439 - 24
By inhibiting Insulin-Like Growth Factor-1-Receptor (IGF-1R) signaling, Klotho (KL) acts like an aging- and tumor-suppressor. We investigated whether KL... 
Translocon | TRPC6 | Calcium | Gemcitabine | Liposarcoma | ER stress | IGF-1 | Klotho | Channels | Cancer | ERK | Life Sciences & Biomedicine | Oncology | Science & Technology | Life Sciences | klotho | calcium | translocon | channels | cancer | gemcitabine | liposarcoma
Journal Article